(Q33749699)

29 July 2017

1 reference

title

Severe community-acquired pneumonia (English)

1 reference

29 July 2017

1 reference

Ewig S

1

1 reference

PubMed ID

10516905

29 July 2017

Torres A

series ordinal

2

1 reference

29 July 2017

1 September 1999

1 reference

Clinics in Chest Medicine

29 July 2017

1 reference

29 July 2017

20

1 reference

29 July 2017

3

1 reference

29 July 2017

575-587

1 reference

The outcome of community acquired pneumonia treated on the intensive care unit

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Prognostic Factors of Pneumonia Requiring Admission to the Intensive Care Unit

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Value of bacterial antigen detection in the diagnostic yield of transthoracic needle aspiration in severe community acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Pneumococcal capsular antigen detection and pneumococcal serology in patients with community acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Use of continuous positive airway pressure in the management of community acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit. The British Thoracic Society Research Committee and The Public Health Laboratory Service

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Severe community-acquired pneumonia: a possible role for Chlamydia pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Phase 1 safety trial of Filgrastim (r-metHuG-CSF) in non-neutropenic patients with severe community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

A comparative study of the effects of almitrine bismesylate and lateral position during unilateral bacterial pneumonia with severe hypoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

The value of open lung biopsy in immunocompetent patients with community-acquired pneumonia requiring hospitalization

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Prognostic analysis and predictive rule for outcome of hospital-treated community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Severe community-acquired pneumonia. Assessment of severity criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Predicting death in patients hospitalized for community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Utility of Fiberoptic Bronchoscopy in Nonresolving Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Community-acquired pneumonia of diverse aetiology: prognostic features in patients admitted to an intensive care unit and a "severity of illness" core.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Effect of Acetylsalicylic Acid on Pulmonary Gas Exchange in Patients With Severe Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Mechanisms of Abnormal Gas Exchange in Patients with Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Effect of indomethacin on arterial oxygenation in critically ill patients with severe bacterial pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Diagnostic fiberoptic bronchoscopy in patients with community-acquired pneumonia. Comparison between bronchoalveolar lavage and telescoping plugged catheter cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Rapidly fatal outcome of bacteremic Klebsiella pneumoniae pneumonia in alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Community acquired pneumonia: aetiology and prognostic index evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Risk factors for pneumonia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Comparative radiographic features of community acquired Legionnaires' disease, pneumococcal pneumonia, mycoplasma pneumonia, and psittacosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Community-acquired pneumonia requiring hospitalization: 5-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Severe Community-Acquired Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Severe community-acquired pneumococcal pneumonia. The French Study Group of Community-Acquired Pneumonia in ICU.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Community acquired pneumonia: aetiology and usefulness of severity criteria on admission

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Granulocyte colony-stimulating factor enhances pulmonary host defenses in normal and ethanol-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Diagnostic fiberoptic bronchoscopy and protected brush culture in patients with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Severe community-acquired pneumonia. Etiology, prognosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Etiology and Diagnosis of Pneumonia Requiring ICU Admission

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

A Three-year Study of Severe Community-acquired Pneumonia With Emphasis on Outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Inhaled nitric oxide for the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Prevalence and diagnosis of Legionella pneumonia: a 3-year prospective study with emphasis on application of urinary antigen detection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Rapid diagnosis of Legionnaires' disease by latex agglutination

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Aetiology and outcome of severe community-acquired pneumonia in Singapore

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Diagnostic value of quantitative cultures of bronchoalveolar lavage and telescoping plugged catheters in mechanically ventilated patients with bacterial pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Diagnostic value of nonfluoroscopic percutaneous lung needle aspiration in patients with pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Severe Community-acquired Pneumonia: Epidemiology and Prognostic Factors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Prospective study of the aetiology and outcome of pneumonia in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

Aetiology and outcome of severe community-acquired pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970237-9

7 January 2021

10.1016/S0272-5231(05)70237-9

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10516905